Abstract
Patients with single ventricle cardiac disease palliated with Fontan procedures inevitably develop Fontan-Associated Liver Disease (FALD), which poses a significant risk for hepatocellular carcinoma (HCC). Standard imaging criteria for the diagnosis of cirrhosis are not reliable due to parenchymal heterogeneity of FALD. We present 6 cases to demonstrate our center’s experience and the challenges in diagnosing HCC within this patient population.
Similar content being viewed by others
Abbreviations
- HCC:
-
Hepatocellular carcinoma
- FALD:
-
Fontan-associated liver disease
- CT:
-
Computed tomography
- BTTs:
-
Blalock-Taussig-Thomas shunt
- AFP:
-
Alpha-fetoprotein
- TARE:
-
Transarterial radioembolization
- MELD-XI:
-
Model for end-stage liver disease-XI
References
Emamaullee J, Zaidi AN, Schiano T et al (2020) Fontan-associated liver disease: screening, management, and transplant considerations. Circulation 142(6):591–604. https://doi.org/10.1161/CIRCULATIONAHA.120.045597
Possner M, Gordon-Walker T, Egbe AC et al (2021) Hepatocellular carcinoma and the Fontan circulation: Clinical presentation and outcomes. Int J Cardiol 322:142–148. https://doi.org/10.1016/j.ijcard.2020.08.057
Egbe AC, Poterucha JT, Warnes CA et al (2018) Hepatocellular carcinoma after fontan operation multicenter case series. Circulation 138(7):746–748. https://doi.org/10.1161/CIRCULATIONAHA.117.032717
American College of Radiology Committee on LI-RADS® (Liver). CT/MRI LI-RADS® V2018 CORE. https://www.acr.org/-/media/ACR/Files/RADS/LI-RADS/LI-RADS-2018-Core.pdf
Wells ML, Hough DM, Fidler JL, Kamath PS, Poterucha JT, Venkatesh SK (2017) Benign nodules in post-Fontan livers can show imaging features considered diagnostic for hepatocellular carcinoma. Abdom Radiol 42(11):2623–2631. https://doi.org/10.1007/s00261-017-1181-9
Golabi P, Fazel S, Otgonsuren M, Sayiner M, Locklear CT, Younossi ZM (2017) Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities. Medicine (United States). https://doi.org/10.1097/MD.0000000000005904
Kogiso T, Sagawa T, Taniai M et al (2022) Risk factors for Fontan-associated hepatocellular carcinoma. PLoS ONE 17(6):e0270230. https://doi.org/10.1371/journal.pone.0270230
De Santiago ER, Téllez L, Guerrero A, Albillos A (2021) Hepatocellular carcinoma after Fontan surgery: a systematic review. Hepatol Res 51(1):116–134. https://doi.org/10.1111/hepr.13582
McGlynn KA, Petrick JL, El-Serag HB (2021) Epidemiology of hepatocellular carcinoma. Hepatology 73(S1):4–13. https://doi.org/10.1002/hep.31288
Evans WN, Acherman RJ, Mayman GA et al (2021) Fontan-associated anatomical variants and hepatic fibrosis. World J Pediatr Congenit Heart Surg 12(2):168–172. https://doi.org/10.1177/2150135120969388
Shiina Y, Inai K, Sakai R, Tokushige K, Nagao M (2022) Hepatocellular carcinoma and focal nodular hyperplasia in patients with Fontan-associated liver disease: characterisation using dynamic gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced MRI. Clin Radiol. https://doi.org/10.1016/j.crad.2022.10.012
Funding
None.
Author information
Authors and Affiliations
Contributions
M.F and K.H. wrote the main manuscript text. S.L. prepared the figure. All authors reviewed and contributed to sections of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest and no financial relationships to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Feeley, M., Hopkins, K., Grinspan, L.T. et al. Challenges in Accurate Diagnosis of HCC in FALD: A Case Series. Pediatr Cardiol 44, 1447–1453 (2023). https://doi.org/10.1007/s00246-023-03207-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-023-03207-9